Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1
NE NEWS SERVICE NEW DELHI, DEC 7 Ahmedabad-based drug firm Zydus Cadila on Monday said it has received permission from ...
NE NEWS SERVICE NEW DELHI, DEC 7 Ahmedabad-based drug firm Zydus Cadila on Monday said it has received permission from ...
Email:
ne.gowri1964@gmail.com
Phone:
9643255068
© 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com